THE POTENTIAL OF CRBN-INDEPENDENT IMID RESENSITIZATION BY EPIGENETIC THERAPY
- 专利权人:
- 发明人:
- 申请号:
- EP16202005.1
- 公开号:
- EP3329923A1
- 申请日:
- 2016.12.02
- 申请国别(地区):
- EP
- 年份:
- 2018
- 代理人:
- 摘要:
- The present invention relates to an epigenetic treatment with a combination of 5-Aza and EPZ-6438 for reversing chromatin accessibility and re-establishment of IMiD sensitivity in cancers such at but not limited to Multiple Myeloma.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- Systems, methods, and formulations to treat cancer
- METHOD FOR PREDICTING THE SENSITIVITY OF A TUMOR TO AN EPIGENETIC TREATMENT
- REPROGRAMMING EFFECTOR PROTEIN INTERACTIONS TO CORRECT EPIGENETIC DEFECTS IN CANCER
- REPROGRAMMING EFFECTOR PROTEIN INTERACTIONS TO CORRECT EPIGENETIC DEFECTS IN CANCER
- Reprogramming effector protein interactions to correct epigenetic defects in cancer